In the News

Croda and BSI partner to fast-track sustainable vaccine adjuvant QS-21 production

Posted: May 2023

Quillibrium® wins Crop Science Award for “Best New Biological Product (Biopesticide)”

Posted: November 2022

Interview with Diego Ibanez, CFO Botanical Solution, Inc.

Posted: August 2022

Adjuvant from baby trees

Posted: June 2022

BSI wins Best Biotech Startup Business of the Year 2022 Award

Posted: May 2022

BSI gains new funding and expands to more countries with new approach to disease control

Posted: February 2022

Empresa chilena de biotecnología en base a quillay obtiene más de US$ 6 millones en financiamiento

Posted: January 2022

Quillay chileno en los ojos de Palo Alto

Posted: January 2022

Innovation grows on trees

Posted: May 2021

Plant-derived fungicide finds larger market

Posted: April 2021

BSI plans further expansion into LATAM markets in partnership with Syngenta

Posted: April 2021

A Conversation with CEO Gaston Salinas

Posted: March 2021

QS-21, the ‘Gold Standard’ of immune system activators used in Covid-19 and other vaccines: CEO Gaston Salinas at BIO

Posted: February 2021

Davis technology company raises funding round for ag, vaccine products

Posted: January 2021

Quillai, an endemic plant in Chile: Impacts on the agricultural and pharmaceutical industry

Posted: December 2020

BSI is set to bring biofungicides to new markets

Posted: November 2020

BSI is set to bring biofungicides to new markets, plus a botanical that could be used in pharma as vaccine adjuvant

Posted: October 2020

BSI expects Latin American approvals for Botristop

Posted: October 2020

BSI found in quillai an effective solution to prevent and control botrytis cinerea

Posted: October 2020

A look at plants for crop protection

Posted: October 2020